These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS. Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624 [TBL] [Abstract][Full Text] [Related]
30. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital]. Bernard Y; Bonnin N; Farguette F; Chiambaretta F J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298 [TBL] [Abstract][Full Text] [Related]
31. CHOROIDAL THICKNESS CHANGES AFTER INTRAVITREAL DEXAMETHASONE IMPLANT INJECTION FOR THE TREATMENT OF MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION. Esen E; Sizmaz S; Demircan N Retina; 2016 Dec; 36(12):2297-2303. PubMed ID: 27870799 [TBL] [Abstract][Full Text] [Related]
32. DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF RECALCITRANT MACULAR EDEMA AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR. Thanos A; Todorich B; Yonekawa Y; Papakostas TD; Khundkar T; Eliott D; Dass AB; Williams GA; Capone A; Faia LJ; Wolfe JD; Hassan TS; Ruby AJ Retina; 2018 Jun; 38(6):1084-1090. PubMed ID: 28622270 [TBL] [Abstract][Full Text] [Related]
33. HYPERREFLECTIVE FOCI AS AN INDEPENDENT VISUAL OUTCOME PREDICTOR IN MACULAR EDEMA DUE TO RETINAL VASCULAR DISEASES TREATED WITH INTRAVITREAL DEXAMETHASONE OR RANIBIZUMAB. Chatziralli IP; Sergentanis TN; Sivaprasad S Retina; 2016 Dec; 36(12):2319-2328. PubMed ID: 27258668 [TBL] [Abstract][Full Text] [Related]
35. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience. Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706 [TBL] [Abstract][Full Text] [Related]
36. Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa. Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Bahcecioglu H J Ocul Pharmacol Ther; 2009 Dec; 25(6):545-50. PubMed ID: 20028262 [TBL] [Abstract][Full Text] [Related]
37. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema. Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343 [TBL] [Abstract][Full Text] [Related]
38. Intravitreal sustained-release dexamethasone implant for the treatment of persistent cystoid macular edema in ocular syphilis. Dutta Majumder P; Mayilvakanam L; Palker AH; Sridharan S; Biswas J Indian J Ophthalmol; 2019 Sep; 67(9):1487-1490. PubMed ID: 31436209 [TBL] [Abstract][Full Text] [Related]
39. Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa. Kim JE Retina; 2006; 26(9):1094-6. PubMed ID: 17151506 [No Abstract] [Full Text] [Related]